Speeding innovation for industry
Success | Diagnosis and innovative treatment
For over 30 years, transcutaneous electrical nerve stimulation has been used treat neuropathic, back, and other chronic pain. However, 20%–40% of patients suffering from chronic pain eschew the technology because of the bulky impulse generator and inconveniently long electrode wires.
Sublimed has replaced these conventional devices with a technology protected by five CEA patents:
A thin and comfortable electric-impulse generator that can run for 20 hours between charges and that can be placed on any part of the body
Skin electrodes, attached to just 10 cm–15 cm of wire
Electronics that can be controlled from a smartphone; the phone can control two to four electrodes and even send the information to a doctor.
The startup hopes that this innovation will increase both patient adoption and treatment efficacy. Partners of the project include pain treatment specialists and the Grenoble University Medical Center Pain Unit.
Resources and skills
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.